Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $272.98M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: EGHT stock price vs EW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EW's multiple
Needs EW P/E.
Implied fair value · at EGHT's multiple
Needs EGHT P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EGHT FY 2026 (ended Mar 31, 2026) · EW FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 46% equity / 54% debt · EV / Revenue 0.68x · EV / EBITDA 9.44x
Capital structure 99% equity / 1% debt · EV / Revenue 7.94x · EV / EBITDA 32.28x
EW carries the larger enterprise value at $48.19B against $501.20M; EGHT trades on the lower EV / Revenue multiple (0.68x vs 7.94x); EGHT on the lower EV / EBITDA (9.44x vs 32.28x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
8x8, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Edwards Lifesciences Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.19x
0.06x
Net debt / EBITDA
Leverage against operating earnings
4.30x
-2.43x
Cash and equivalents
Liquid reserves on the balance sheet
$93.26M
$4.23B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoom Communications, Inc.
EGHT vs ZM
CISCO SYSTEMS, INC.
EGHT vs CSCO
TWILIO INC
EGHT vs TWLO
RingCentral, Inc.
EGHT vs RNG
Five9, Inc.
EGHT vs FIVN
ABBOTT LABORATORIES
EGHT vs ABT
JOHNSON & JOHNSON
EGHT vs JNJ
Medtronic plc
EGHT vs MDT
BOSTON SCIENTIFIC CORP
EGHT vs BSX
BAXTER INTERNATIONAL INC
EGHT vs BAX
DENTSPLY SIRONA Inc.
EGHT vs XRAY
$321.48M
$598.30M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
